Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Charly

<< Previous

Bullboard Posts

Next >>

Comment by Charly50on Sep 17, 2021 11:05am

102 Views

Post# 33877319

RE:RE:RE:RE:RE:RE:RE:RE:Charly

Thank you for providing this article.

Very good BIO!

"Tomei, meanwhile, is focusing on microencapsulation and has developed a hydrogel coating for cells that excludes immune cells while allowing β-cell function 8 . She is collaborating with Sernova, a regenerative medicine company in London, Canada, on an approach in which a bag of cells is inserted under the skin two weeks before microencapsulated islets are introduced. During this two-week period, new blood vessels enter the pouch and initial inflammation subsides - both of which should help the islets grow. Sernova is currently investigating a basic cellular pouch in a Phase I/II study."

Let's see what's new on Monday....

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec